InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Cashman Christopher Michael. Director active across 1 company, notably Marinus Pharmaceuticals INC. Cumulatively, 2 reports have been logged. Breakdown: 1 buy · 0 sell. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations